Procter: companies and medicines worldwide

Loading your page…

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 585

Medicine	Substance	Country	Status	Authorised
2IN1 MEN ADVANCED SERIES BOURBON1 % / w/w · Shampoo	Pyrithione zinc	Canada	Not marketed	2020
2IN1 MEN ADVANCED SERIES CHARCOAL1 % / w/w · Shampoo	Pyrithione zinc	Canada	Not marketed	2019
2IN1 MEN ADVANCED SERIES SAGE & MINT1 % / w/w · Shampoo	Pyrithione zinc	Canada	Not marketed	2020
7 IN ONE TONE CORRECTING CC CREAM WITH SPF2 % / w/w + 3 % / w/w + 3 % / w/w · Cream	Avobenzone, Octisalate, Octocrylene	Canada	Marketed	2021
AGE DEFYING ANTI-WRINKLE LOTION WITH SPF3 % / w/w + 4 % / w/w + 4.5 % / w/w + 2.6 % / w/w · Lotion	Avobenzone, Homosalate, Octisalate, Octocrylene	Canada	Marketed	2016
AGE DEFYING CLASSIC LOTION WITH SPF6 % / w/w + 3 % / w/w · Lotion	Octinoxate, Zinc oxide	Canada	Marketed	2017
ALGINAC	Vitamin b12, Vitamin b1, Vitamin b6, Diclofenac	Brazil	Authorised	2019
ALOE VERA 2IN11 % / w/w · Shampoo	Pyrithione zinc	Canada	Not marketed	2020
BARE MINIMAL INGREDIENTS 2IN1 SHAMPOO PURE CLEAN1 % / w/w · Shampoo	Pyrithione zinc	Canada	Marketed	2025
BARE MINIMAL INGREDIENTS ITCH CONTROL SERUM0.1 % / w/w · Shampoo	Pyrithione zinc	Canada	Marketed	2026
BARE MINIMAL INGREDIENTS SHAMPOO ITCH CONTROL1 % / w/w · Shampoo	Pyrithione zinc	Canada	Marketed	2025
BARE MINIMAL INGREDIENTS SHAMPOO PURE CLEAN1 % / w/w · Shampoo	Pyrithione zinc	Canada	Marketed	2024
BARE MINIMAL INGREDIENTS SHAMPOO SENSITIVE SCALP CARE1 % / w/w · Shampoo	Pyrithione zinc	Canada	Marketed	2026
BARE MINIMAL INGREDIENTS SHAMPOO SOOTHING HYDRATION1 % / w/w · Shampoo	Pyrithione zinc	Canada	Marketed	2024
BRIGHTENING DAILY FACIAL MOISTURIZER WITH SPF3 % / w/w + 9 % / w/w + 4.5 % / w/w + 6 % / w/w · Lotion	Avobenzone, Homosalate, Octisalate, Octocrylene	Canada	Authorised
CEBIONCompressa masticabile	Ascorbic acid	Italy	Authorised
CITONEURIN	Vitamin b12, Vitamin b1, Vitamin b6	Brazil	Authorised	2019
COMPLETE + FACIAL MOISTURIZER WITH SPF BROAD SPECTRUM SPF 403 % / w/w + 10 % / w/w + 5 % / w/w + 9 % / w/w · Lotion	Avobenzone, Homosalate, Octisalate, Octocrylene	Canada	Marketed	2024
COMPLETE HYDRATING CREAM WITH SPF3 % / w/w + 4 % / w/w + 4.5 % / w/w + 2.6 % / w/w · Cream	Avobenzone, Homosalate, Octisalate, Octocrylene	Canada	Marketed	2017
COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM 15 FOR COMBINATION/OILY SKIN3 % + 4 % + 4.5 % + 2.6 % · Lotion	Avobenzone, Homosalate, Octisalate, Octocrylene	Canada	Marketed	2017
COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 153 % + 4 % + 4.5 % + 2.6 % · Lotion	Avobenzone, Homosalate, Octisalate, Octocrylene	Canada	Marketed	2017
COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 15 SENSITIVE6 % / w/w + 3 % / w/w · Lotion	Octinoxate, Zinc oxide	Canada	Marketed	2018
COMPLETE LIGHTWEIGHT LOTION WITH SPF BROAD SPECTRUM SPF 307.5 % / w/w + 2.5 % / w/w + 2.5 % / w/w + 6.9 % / w/w · Lotion	Octinoxate, Octisalate, Octocrylene, Zinc oxide	Canada	Marketed	2018
CREST PRO-HEALTH COMPLETE CLEAN0.07 % / w/w · Mouthwash	Cetylpyridinium	Canada	Marketed	2026
CREST PRO-HEALTH GERM GUARD0.07 % / w/w · Mouthwash	Cetylpyridinium	Canada	Marketed	2021

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Canada	515	219	296	Companies All medicines
Brazil	38	13	25	Companies All medicines
Italy	12	12	0	Companies All medicines
Netherlands	7	7	0	Companies All medicines
Singapore	6	6	0	Companies All medicines
United States	3	3	0	Companies All medicines
Spain	2	1	1	Companies All medicines
Saudi Arabia	2	2	0	Companies All medicines

Also in the registers of United Kingdom

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

ANVISA / CMED

ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date

Licence: Other (Public Domain)

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

All 14 sources

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

Report an error or request removalCorrections from the company itself are welcome.

Procter

Group structure

Brazil5

Canada4

Know your medicines, with the sources.

Procter

Group structure

Brazil5

Canada4

Know your medicines, with the sources.

Spain2

Italy1

Netherlands1

Saudi Arabia1

Singapore1

United Kingdom1

United States1

Medicines

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇧🇷Brazil5

🇨🇦Canada4

Know your medicines, with the sources.

Group structure

🇧🇷Brazil5

🇨🇦Canada4

Know your medicines, with the sources.

🇪🇸Spain2

🇮🇹Italy1

🇳🇱Netherlands1

🇸🇦Saudi Arabia1

🇸🇬Singapore1

🇬🇧United Kingdom1

🇺🇸United States1

Medicines

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Brazil5

Canada4

Brazil5

Canada4

Spain2

Italy1

Netherlands1

Saudi Arabia1

Singapore1

United Kingdom1

United States1